The undersigned hereby agree that the statement on Schedule 13G with respect to Common Stock of Prenetics Global Limited dated as of 29 December 2023 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Date: 5 February 2024
By:
Name: Lim Siew May
Title: Director - Global Shareholding Reporting
By:
Name: Dicky Lam
Title: Chief Financial Officer